Partners, Collaborators and Investors

Iscaffpharma provides a cost-effective platform to improve success rate in clinical development of treatments for aggressive cancer

Partner with us!

Iscaffpharma will partner with pharmaceutical companies based on co-development and license agreements. We will:

  • License and sell 3D printed scaffolds, with the possibilty of support for analyses
  • Offer verification of 3D results in human scaffolds
  • Offer target and drug screening

In addition, we will develop our own cancer drug portfolio based on the platform. Our main Focus is on solid cancer:

  • Breast
  • Colon
  • Ovarian
  • Orphan
  • Moving in to other forms

Iscaffpharma will seek partnerships for commercialization of NCEs from our own portfolio.
We will develop our technology as a cost-effective platform to improve success rate in clinical development of treatments for aggressive cancer.

Contact contact@iscaffpharma.com for more information

Partners, Collaborators and Investors

Iscaffpharma is part of UDI3 challenge driven innovation supported by Vinnova. Our partners are:

vgregunivhosp_o-01
1593648_guv.rgb_
skanes-universitetssjukhus-logga
tataa_logo_liggande_a4_cmyk_300dpi
vinnova_green_payoff_en_rgb
1514062_sacancercenter-kopia
cellprotect-pharmaceuticals
bioinvent
respiratorius-logo03-black-200712
logueng_cen2r
fullsizeoutput_116f
rise_logo_rgb_dr44mov
oblique
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search